Relationship between the RAS mutation and clinical prognosis in papillary thyroid carcinoma
10.3760/cma.j.issn.1007-631X.2014.01.014
- VernacularTitle:甲状腺乳头状癌RAS基因突变与临床预后的关系
- Author:
Liang SHEN
;
Shuai ZHANG
;
Weili GU
;
Di HUANG
;
Mianling CHEN
;
Liusen LIANG
- Publication Type:Journal Article
- Keywords:
Thyroid neoplasms;
Carcinoma,papillary;
Prognosis;
Point mutation
- From:
Chinese Journal of General Surgery
2014;29(1):44-48
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the RAS gene mutations in papillary thyroid carcinoma,and to analyse the effects of mutation on clinical characteristics and prognosis.Methods In this study,354 papillary thyroid carcinoma patients were divided into 2 groups according to RAS mutation by DNA sequence analysis.The pathological type,disease progression,recurrence and prognostic difference between the two groups were compared,and regression analysis was performed to evaluate the relationship between different variables and RAS mutation.Results There were 86 patients with RAS positive mutation.A significant difference was found with primary sites (P =0.004),distant metastasis (P =0.027),AJCC stage (P =0.004) and ATA risk stratification (P =0.000) between two groups.RAS positive patients have higher recurrence rate and shorter recurrence-free survival time (P ＜ 0.005) than the negative patients.Furthermore,in the multivariate analysis,the RAS mutation was significantly associated only with the ATA stratification.Conclusions RAS mutation increases risk of recurrence,RAS mutation and ATA stratification might be a valuable diagnostic and prognostic marker of papillary thyroid carcinoma.
